Inventor · disambiguated record
Joseph Panarese
Also filed as: PANARESE JOSEPH D · PANARESE JOSEPH DAVID · Panarese Joseph
36 granted patents·11 pending applications·202 citations·filing 2014–2025
96Inventor score
Top patents by PatentIndex Score
47 records- 0198US11384090B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jul 12, 2022·14 cites·15 claims
- 0298US11352363B1Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jun 7, 2022·13 cites·9 claims
- 0398US11319325B1Macrocyclic spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 3, 2022·14 cites·24 claims
- 0498US10865215B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Dec 15, 2020·16 cites·13 claims
- 0598US10358441B2Processes for the preparation of benzodiazepine derivativesENANTA PHARM INC·Filed 2018·Granted Jul 23, 2019·27 cites·18 claims
- 0697US11858945B2Alkyne-containing antiviral agentsENANTA PHARM INC·Filed 2022·Granted Jan 2, 2024·7 cites·16 claims
- 0797US11390631B1Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Jul 19, 2022·4 cites·10 claims
- 0897US9957281B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2016·Granted May 1, 2018·32 cites·18 claims
- 0995US11358953B2Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jun 14, 2022·15 cites·10 claims
- 1095US10398706B2Heteroaryldiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Sep 3, 2019·26 cites·11 claims
- 1194US10865211B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2019·Granted Dec 15, 2020·11 cites·17 claims
- 1293US11891393B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2021·Granted Feb 6, 2024·2 cites·20 claims
- 1393US11198693B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2019·Granted Dec 14, 2021·6 cites·20 claims
- 1492US11058678B2Substituted heterocycles as antiviral agentsENANTA PHARM INC·Filed 2019·Granted Jul 13, 2021·7 cites·21 claims
- 1589US12297209B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2024·Granted May 13, 2025·0 cites·5 claims
- 1689US10570153B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Feb 25, 2020·4 cites·34 claims
- 1783US12264159B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2023·Granted Apr 1, 2025·0 cites·19 claims
- 1882US11952389B2Benzodiazepine derivatives as RSV inhibitorsENANTA PHARM INC·Filed 2022·Granted Apr 9, 2024·0 cites·9 claims
- 1982US2025326768A1Benzodiazepine Derivatives as RSV InhibitorsENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 2079US9540371B2Substituted quinazolin-4(3H)-ones, pyrido[3,4-d]pyrimidin-4(3H)-ones, pyrido[3,2-d]pyrimidin-4(3H)-ones and pyrido[2,3-d]pyrimidin-4(3H)-ones as positive allosteric modulators of muscarinic acetycholine receptor M1UNIV VANDERBILT·Filed 2014·Granted Jan 10, 2017·2 cites·12 claims
- 2176US9527834B2Substituted 1-benzylquinoxalin-2(1H)-one analogs as positive allosteric modulators of muscarinic acetylcholine receptor M1UNIV VANDERBILT·Filed 2014·Granted Dec 27, 2016·1 cites·16 claims
- 2273US9708278B2Substituted 4-benzyl-3,4-dihydro-2H-benzo[B][1,4]oxazine-2-carboxamide analogs as positive allosteric modulators of muscarinic acetycholine receptor M1UNIV VANDERBILT·Filed 2014·Granted Jul 18, 2017·1 cites·20 claims
- 2368US2022041652A1Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Application pending·0 cites
- 2467US2022033383A1Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Application pending·0 cites
- 2566US10906895B2Processes for the preparation of benzodiazepine derivativesENANTA PHARM INC·Filed 2019·Granted Feb 2, 2021·0 cites·17 claims
- 2665US12268694B2Combination pharmaceutical agents as RSV inhibitorsENANTA PHARM INC·Filed 2020·Granted Apr 8, 2025·0 cites·4 claims
- 2765US2025154163A1Pyrimidinone-Containing 17-Beta-Hydroxysteroid Dehydrogenase Type 13 InhibitorsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 2863US11993600B2Saturated spirocyclics as antiviral agentsENANTA PHARM INC·Filed 2022·Granted May 28, 2024·0 cites·16 claims
- 2962US11377450B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2020·Granted Jul 5, 2022·0 cites·21 claims
- 3061US2023416268A1Pyrimidinone-containing 17-beta-hydroxysteroid dehydrogenase type 13 inhibitorsENANTA PHARM INC·Filed 2023·Application pending·0 cites
- 3161US2024325409A1Fused Heterotetracyclic Antiviral AgentsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 3260US2024368096A1Fused Heterobicyclic Antiviral AgentsENANTA PHARM INC·Filed 2024·Application pending·0 cites
- 3359US12398147B2Macrocyclic spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Aug 26, 2025·0 cites·17 claims
- 3459US11976084B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 7, 2024·0 cites·16 claims
- 3559US10759816B2Heterocyclic compounds as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Sep 1, 2020·0 cites·20 claims
- 3658US12479854B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Nov 25, 2025·0 cites·22 claims
- 3758US12145941B2Heterocyclic antiviral agentsENANTA PHARM INC·Filed 2022·Granted Nov 19, 2024·0 cites·14 claims
- 3858US2024140922A1Fused heterobicyclic antiviral agentsENANTA PHARM INC·Filed 2023·Application pending·0 cites
- 3955US2017226129A1Heterocyclic compounds as rsv inhibitorsENANTA PHARM INC·Filed 2017·Application pending·0 cites
- 4054US11802125B2Functionalized heterocyclic compounds as antiviral agentsENANTA PHARM INC·Filed 2021·Granted Oct 31, 2023·0 cites·9 claims
- 4154US10881666B2Combination pharmaceutical agents as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Jan 5, 2021·0 cites·20 claims
- 4254US2022048944A1Functionalized peptides as antiviral agentsENANTA PHARM INC·Filed 2021·Application pending·0 cites
- 4353US11738019B2Substituted heterocycles as antiviral agentsENANTA PHARM INC·Filed 2020·Granted Aug 29, 2023·0 cites·15 claims
- 4452US11236108B2Functionalized heterocycles as antiviral agentsENANTA PHARM INC·Filed 2020·Granted Feb 1, 2022·0 cites·15 claims
- 4545US2025304542A1Fused Heterobicyclic Antiviral AgentsENANTA PHARM INC·Filed 2025·Application pending·0 cites
- 4644US11091501B2Heterocyclic compounds as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Aug 17, 2021·0 cites·19 claims
- 4744US10851115B2Heterocyclic compounds as RSV inhibitorsENANTA PHARM INC·Filed 2018·Granted Dec 1, 2020·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Joseph Panarese files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →